May 10, 2022 / 03:00PM GMT
Kevin Mark Fischbeck - BofA Securities, Research Division - MD in Equity Research
Thank you for joining us today. It's my pleasure to be kicking off the conference with DaVita. DaVita is the largest provider of dialysis -- pure-play provider of dialysis.
And with us today, we have Joel Ackerman, who's the CFO. Joel, thanks for being here.
Joel Ackerman - DaVita Inc. - CFO & Treasurer
It's good to be here.
Questions and Answers:
Kevin Mark Fischbeck - BofA Securities, Research Division - MD in Equity ResearchSo Joel was crazy enough to allow me to jump right into Q&A. If -- and then depending on any questions, by all means, you can ask them, but I'll start it off for sure. I guess when we think about you guys have provided this 3% to 7% OI growth estimate over time. I mean can you just kind of walk us through the building blocks. I mean a lot of things that happen around COVID and costs? And should we still be thinking about the 3% to 7% as the right number over time?
Joel
Trustpilot
